scientific program • symposia - American Society for Reproductive ...

O-130 5:30 PM
EXPERIENCE WITH GAY MALE COUPLES USING IVF FOR
FAMILY-BUILDING: CYCLE DYNAMICS AND CLINICAL AND
LABORATORY OUTCOMES.
D. L. Cunningham, S. C. Pang, A. Moegle, K. J. Go. Reproductive
Science Center of New England, Lexington, MA.
O-131 5:45 PM
EVALUATING THE USE OF MONTHLY PATIENT ENGAGEMENT
METRICS AS A NURSING-SENSITIVE QUALITY INDICATOR.
C. M. Bergh 1 , D. D. Burke 1 , P. A. Bergh 1,2 . 1 Reproductive Medicine
Associates of New Jersey, Morristown, NJ; 2 Division of Reproductive
Endocrinology, Department of Obstetrics and Gynecology, UMDNJ-
Robert Wood Johnson Medical School, New Brunswick, NJ.
O-132 6:00 PM
A PROSPECTIVE OBSERVATIONAL STUDY TO ASSESS EASE OF
LEARNING, USE AND OVERALL PATIENT SATISFACTION OF NEW
FOLLITROPHIN-ALPHA PREFILLED-PEN, COMPARED TO THE
OTHER SYSTEMS OF GONADOTROPIN ADMINISTRATION.
T. Utsunomiya 1 , K. Takahashi 1 , K. Tatsumi 1 , D. Ezcurra 2 . 1 Japan
Institution for Standardizing Assisted Reproductive Technology,
Osaka, Kansai, Japan; 2 Merck Serono S.A.Geneva, Geneva,
Switzerland.
__________________________________________________________
ANDROGEN EXCESS
ROOM 330 A
Moderators: Atoni Duleba
Jean-Patrice Baillargeon
O-133 4:15 PM
PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME (PCOS)
HAVE DECREASED SERUM LEVELS OF THECA CELL DERIVED
BONE MORPHOGENETIC PROTEIN-7 (BMP-7): A NEW
HORMONAL MARKER?
O. Oktem, B. Urman. Women’s Health Center Assisted Reproduction
Unit, American Hospital, Istanbul, Turkey.
O-134 4:30 PM
VARIANTS IN DEHYDROEPIANDROSTERONE
SULFOTRANSFERASE (SULT2A1) ARE INVOLVED IN THE
REGULATION OF DEHYDROEPIANDROSTERONE (DHEA)/
DHEA-SULFATE (DHEAS) LEVELS IN THE POLYCYSTIC OVARY
SYNDROME.
Y. V. Louwers 1 , N. van Herwaarden 1 , L. Stolk 2 , A. G. Uitterlinden 2,3 , F.
H. de Jong 2 , J. S. E. Laven 1 . 1 Department of Reproductive Medicine,
ErasmusMC University Medical Center, Rotterdam, Netherlands;
2 Department of Internal Medicine, ErasmusMC University Medical
Center, Rotterdam, Netherlands; 3 Department of Epidemiology,
ErasmusMC University Medical Center, Rotterdam, Netherlands.
O-135 4:45 PM
RESVERATROL POTENTIATES EFFECTS OF SIMVASTATIN ON
INHIBITION OF RAT OVARIAN THECA-INTERSTITIAL CELL
STEROIDOGENESIS.
I. Ortega 1,2 , A. B. Cress 1 , J. A. Villanueva 1 , A. Sokalska 1,3 , S. D.
Stanley 4 , A. J. Duleba 1 . 1 Department of Obstetrics and Gynecology,
University of California, Davis, Davis, CA; 2 IVI Madrid, Madrid,
Spain; 3 Department of Gynecology, Obstetrics and Gynecological
Oncology, Karol Marcinkowski, Poznan, Poland; 4 Department of
Molecular Biosciences, University of California, Davis, Davis, CA.
O-136 5:00 PM
METFORMIN INHIBITS CELL PROLIFERATION AND CELL CYCLE
REGULATORY PROTEINS OF OVARIAN THECA-INTERSTITIAL
CELLS.
M. A. Will, M. Palaniappan, H. Peegel, P. Kayampilly, K. M. J. Menon.
Obstetrics and Gynecology, University of Michigan Hospitals, Ann
Arbor, MI.
ORAL ABSTRACTS
113
O-137 5:15 PM
THE IMPACT OF SUPERVISED WEIGHT LOSS AND WEIGHT
REGAIN ON THE ANDROGENIC SEX HORMONE PROFILE:
SEX HORMONE BINDING GLOBULIN IS THE MOST SENSITIVE
MARKER OF WEIGHT FLUCTUATIONS.
M. Aubuchon 1 , A. J. Polotsky 2 , Y. Liu 3 , T. R. Thomas 3 . 1 Obstetrics,
Gynecology, and Women’s Health, University of Missouri School of
Medicine, Columbia, MO; 2 Obstetrics and Gynecology, University
of Colorado Denver, Aurora, CO; 3 Nutrition & Exercise Physiology-
Health and Exercise Science, University of Missouri School of
Medicine, Columbia, MO.
O-138 5:30 PM
ANDROGEN ADMINISTRATION IN NORMAL REPRODUCTIVE-
AGE WOMEN PROMOTES PROATHEROGENIC INFLAMMATION
AS CHARACTERIZED IN POLYCYSTIC OVARY SYNDROME
(PCOS).
F. González 1 , K. S. Nair 2 , E. Basal 2 , D. M. Bearson 2 , J. M. Schimke 2 , H.
E. Blair 2 . 1 Obstetrics and Gynecology, Indiana University School of
Medicine, Indianapolis, IN; 2 (a) Internal Medicine, (b) Obstetrics and
Gynecology, and (c) Laboratory Medicine and Pathology, College
of Medicine, Mayo Clinic, Rochester, MN.
O-139 5:45 PM
HISTORY OF OLIGOMENORRHEA AUGMENTS THE
ASSOCIATION OF HYPERANDROGENEMIA WITH METABOLIC
SYNDROME: EVIDENCE FOR A PCOS PHENOTYPE IN THE STUDY
OF WOMEN’S HEALTH ACROSS THE NATION (SWAN).
A. J. Polotsky 1 , A. Allshouse 1 , S. L. Crawford 5 , S. D. Harlow 2 , N. Khalil 3 ,
R. S. Legro 4 . 1 Obstetrics and Gynecology, University of Colorado,
Aurora, CO; 2 Epidemiology, University of Michigan, Ann Arbor,
MI; 3 Community Health, Boonshoft School of Medicine, Dayton,
OH; 4 Obstetrics and Gynecology, Pennsylvania State University,
Hershey, PA; 5 Preventive and Behavioral Medicine, University of
Massachusetts Medical School, Worcester, MA..
O-140 6:00 PM
COMPARATIVE STUDY OF THE THERAPEUTIC EFFECTS OF ORAL
PILLS CONTAINING DESOGESTREL, CYPROTERONE ACETATE
AND DROSPIRENONE, IN PATIENTS WITH POLYCYSTIC OVARY
SYNDROME (PCOS).
S. M. Bhattacharya 1 , A. Jha 3 . 1 Obstetrics & Gynecology, S.C. Das
Memorial Medical & Research Center, Kolkata, West Bengal,
India; 2 Obstetrics & Gynecology, KPC Medical College, Kolkata,
West Bengal, India; 3 Division of Epidemiology and Communicable
diseases(ECD), Indian Council of Medical Research (ICMR) Head
Quarters, New Delhi, India.
__________________________________________________________
CRYOPRESERVATION AND FROZEN EMBRYO TRANSFER –
CLINICAL: ART
ROOM 330 B
Moderators: Samantha Pfeifer
O-141 4:15 PM
SAFETY OF PREGNANCY AFTER LETROZOLE-FSH STIMULATION
IN BREAST CANCER PATIENTS: A PROSPECTIVE COMPARISON
OF FROZEN EMBRYO TRANSFER TO SELF VS. GESTATIONAL
CARRIERS.
K. Oktay1,3 , E. Arslan1 , M. Karsy1,2 , F. Moy1,2 . 1Department of Obstetrics
& Gynecology, Institute for Fertility Preservation, Laboratory of
Molecular Reproduction, New York Medical College, Valhalla, NY;
2Department of Pathology, New York Medical College, Valhalla, NY;
3Department of Cell Biology & Anatomy, New York Medical College,
Valhalla, NY.